Summit Financial, LLC
Source: SEC Form 13F · as of Mar 2026Summit Financial, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $39.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$39.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 16,466 | $12.7M |
| AXSMAxsome Therapeutics, Inc. | 65,249 | $11.0M |
| GILDGILEAD SCIENCES, INC. | 32,149 | $4.5M |
| AVXLANAVEX LIFE SCIENCES CORP. | 940,455 | $2.9M |
| TGTXTG THERAPEUTICS, INC. | 85,393 | $2.8M |
| VKTXViking Therapeutics, Inc. | 61,169 | $2.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 15,731 | $876K |
| MDWDMediWound Ltd. | 47,271 | $762K |
| ESPREsperion Therapeutics, Inc. | 126,373 | $346K |
| VERUVERU INC. | 151,783 | $335K |
| INSMINSMED Inc | 2,040 | $334K |
| TAOXTAO Synergies Inc. | 43,275 | $246K |
| MRNAModerna, Inc. | 4,434 | $225K |
| DRTSAlpha Tau Medical Ltd. | 30,000 | $212K |
| CHRSCoherus Oncology, Inc. | 112,088 | $189K |
| ELTXElicio Therapeutics, Inc. | 10,010 | $107K |
| CMPSCOMPASS Pathways plc | 12,194 | $67K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.